Detalles de la búsqueda
1.
Epigenetic therapy inhibits metastases by disrupting premetastatic niches.
Nature
; 579(7798): 284-290, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32103175
2.
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Oncology (Williston Park)
; 37(4): 176-183, 2023 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104758
3.
Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease.
Acta Oncol
; 61(6): 705-713, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35435129
4.
Development and validation of a prediction model of poor performance status and severe symptoms over time in cancer patients (PROVIEW+).
Palliat Med
; 35(9): 1713-1723, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34128429
5.
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Lancet Oncol
; 21(8): 1066-1076, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32653053
6.
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study.
Lancet Oncol
; 18(1): 31-41, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27932067
7.
Oncology care provider perspectives on exercise promotion in people with cancer: an examination of knowledge, practices, barriers, and facilitators.
Support Care Cancer
; 25(7): 2297-2304, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28258503
8.
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement.
Curr Oncol
; 31(4): 1803-1816, 2024 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38668039
9.
Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response.
Curr Oncol
; 31(1): 1-23, 2023 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38275827
10.
Immune-Checkpoint Induced Skin Toxicity Masked as Squamous Cell Carcinoma: Case Report on Mimickers of Dermatological Toxicity with PD-1 Inhibition.
Curr Oncol
; 30(5): 4527-4537, 2023 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37232800
11.
Neuroanatomical location of brain metastases from solid tumours based on pathology: An analysis of 511 patients with a comparison to the provided clinical history.
PLoS One
; 18(11): e0294154, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37943775
12.
Prevalence of Thyroid Transcription Factor-1 (TTF-1)-Negative Small Cell Carcinoma and Napsin A Positivity in Small Cell Carcinoma in a Cross-Sectional Study of Lung Core Biopsies.
Cureus
; 15(4): e37015, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37139017
13.
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer.
Curr Oncol
; 30(7): 6289-6315, 2023 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37504325
14.
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC.
Curr Oncol
; 30(7): 6473-6496, 2023 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37504336
15.
Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience.
Curr Oncol
; 30(7): 6559-6574, 2023 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37504341
16.
Physician and Surgeon Communication Assessed via the Pathology Requisition in a Regional Laboratory Over Ten Years.
Cureus
; 14(8): e27714, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36081978
17.
The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer.
Ther Adv Med Oncol
; 14: 17588359221112696, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35923926
18.
BMS-986012, an Anti-Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study.
JTO Clin Res Rep
; 3(11): 100400, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36275912
19.
The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer.
Curr Oncol
; 28(6): 4392-4407, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34898551
20.
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer.
Ther Adv Med Oncol
; 13: 17588359211056306, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34804219